<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>&#13;
&#13;
<head>&#13;
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>&#13;
    <link href="./static/css/outliers.css" rel="stylesheet"/>&#13;
    <meta charset="UTF-8"/>&#13;
</head>&#13;
&#13;
<body>&#13;
    <div class="container"><h1>Static outliers for Mendlesham Medical Group</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=practice+D83019">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where Mendlesham Medical Group is higher than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0501021G0&amp;denomIds=5.1.2&amp;selectedTab=summary">Ceftriaxone sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>3</td>&#13;
      <td>Cephalosporins</td>&#13;
      <td>57</td>&#13;
      <td>0.05</td>&#13;
      <td>0.00</td>&#13;
      <td>0.01</td>&#13;
      <td>6.77</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0501021G0AAADAD&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Ceftriaxone 2g powder for solution for injection vials : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0501021G0AAACAC&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Ceftriaxone 1g powder for solution for injection vials : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0601023AC&amp;denomIds=6.1.2&amp;selectedTab=summary">Saxagliptin</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>200</td>&#13;
      <td>Other antidiabetic drugs</td>&#13;
      <td>1143</td>&#13;
      <td>0.17</td>&#13;
      <td>0.01</td>&#13;
      <td>0.02</td>&#13;
      <td>6.64</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0601023ACAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Saxagliptin 5mg tablets : 177</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0601023ACAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Saxagliptin 2.5mg tablets : 23</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0301020R0&amp;denomIds=3.1.2&amp;selectedTab=summary">Aclidinium bromide</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>85</td>&#13;
      <td>Antimuscarinic bronchodilators</td>&#13;
      <td>195</td>&#13;
      <td>0.44</td>&#13;
      <td>0.04</td>&#13;
      <td>0.07</td>&#13;
      <td>5.72</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAF40lEQVR4nO3dW4gVdQDH8e+UpqlYRpcXs6Eww6jMsPKC3SiViZJIiHyoCCQkKqh0XiKpwCkpkozEh24UWD0o2mTUhhVGhthFTcKEJn2JINdswfX672H+h85O47pnZ2fmzJnfB4aZo7szP4/nNzPnvzNnHWMMIlIPZ5QdQESKo8KL1IgKL1IjKrxIjajwIjWiwovUiAovUiMqvEiNqPAiNaLCi9SICi+SleNU5vr0YVm+2fXDu4BFwIfA+ijwDg1JKhHJRdYj/MvAe8CNwC7XD5dlTiQiucla+A1R4K2NAm8xMBFY4PrhdUOQS0RykLXwzzcWosA7AjwOvO76ocYGRNpQpmJGgXcw8bgL2Ac8lGW9IpKPPI7ETwLPuH54Xg7rFpEMhrzwUeDtB96g6XRfRNpDXu+1XwVud/1wUk7rF5FByKXwdgDvWWB5HusXkcHJczT9A2CC64czctyGiLQgt8JHgXcSWAqscP3QyWs7IjJwuf68PAq8L4B/gLvz3I6IDEwRF8gsAQLXD8cUsC0R6UfuhY8CbwfxzTUv5b0tEelfUZfAvgDc4PrhnIK2JyIpnKJ+1ZTrh5OBjcC0KPAOFLJRkSI4jsGYSgxMF3aTSxR4u4FVwGqN2ouUo+i72lYCZwJBwdsVEQouvP3Z/EJgmuuHTxW5bREp4TPtosDrBeYD97l++GDR2xeps8IG7ZJcP7wQ6ALWRIG3qpQQIkOhQoN2pRUewPXDccA6YBuw1J7yi1RLhQpf6kdRRYHXDcwBxgNrdTWeSL5K/+w5eyvtQmAX8J3rh1NLjiTSsUo9pU9y/XAW8BbxJ+asjALvRMmRRE5Pp/SDEwXeFuB6YCqwzfXD2SVHEukobXWEb+b64Uzij8r6DXguCrxdJUcSSVehI3zbFh7Afr79/cDTwB/AK8DnGs2XtqLCDy177f1twBPAZOAj4H1gZxR47f8PkM6mwufHXrCzgPjIfxHwGbAJ2BwFXk+Z2aSmVPhiuH54PnAHMBe4BdhDXP4uYIdO/aUQKnzx7Pv9a4F5wK3AJGA78DXwFfBDFHjHy0soHUuFL5/rhyOAacBs4CbgKmA38CPwk53/EgXesdJCSmdQ4duP64fDgSuBa+w0BbiCePT/Z+B34l+Euc8u79eYgAyICl8NdvR/PPHI/8XAhMQ0GjgC/A0csvPG8uHTTL2Jx4eAbqBHP1noMCp857BvDc4Bxtp5Y3kUcDYw0s5PNY20XzsWOBcYAzhAD3CQeCfQbZd7iHcwR+3UvHwMOG7nadNR4p1MYzrc/Fg7mRyp8NIfe2YxGhhHvBNozMcAZwEjUubDgOFNU/Jx4+uad0KN+Qj+u4y6+T/8pJ1OpCwn50P5dydtjqIm8lx/9OKdq9ylHy8uKCuAiQJvPYOQqfCO4ywyxqwZ9AoKVrW8UL3MVcsL1cucJW/Wm2cWZfz+olUtL1Qvc9XyQvUyDzpvW90tJyL5UuFFaiRr4SvzvseqWl6oXuaq5YXqZR50Xo3Si9SITulFamRYK1/sOM5sYAbwpzHmTcdx7gEuA/YaY9blETCrlMzzgbnGmEdKjpYqJe8DxJcEbzLGbC43XbqUzPOIb2TaaYzZWG66/0vmtX+2GnjbGLO11HCnkPIcLyO+WOsTY8yega6n1SP8dGNMAFxgH080xqwALm9xPUXqk9kYsx6ISk3Uv2Ted4DVwKWlpupf8nWxlfhS5d7yIvWrT1574Pqy1ESnl3yO/yK+eKslrRY++Ya/CgMAVcjYrE9ex3FGAw8D75YTZ0D6ZDbGdAOP0r47qeRr4mpgFjCzhCwDlXyOXwOWA/e2spKWBu3sacV04ADwPXAJ8Sn9r/bI2XZSMo8ClgCBMeabMrOlScn7GLAX6DLGfFtmtlNJyTyF+HWx1RizocxsaZJ5jTHbHce5Geht81P65uf4cuK3eluMMZ8OeD0apRepD43Si9SICi9SIyq8SI2o8CI1osKL1IgKL1IjKrxIjajwIjWiwovUiAovUiMqvEiN/AutModsPQ4FYgAAAABJRU5ErkJggg=="/></td>&#13;
    </tr>&#13;
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0301020R0BBAAAA&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Eklira 322micrograms/dose Genuair : 85</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1003020R0&amp;denomIds=10.3.2&amp;selectedTab=summary">Piroxicam</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>172</td>&#13;
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>&#13;
      <td>404</td>&#13;
      <td>0.43</td>&#13;
      <td>0.05</td>&#13;
      <td>0.09</td>&#13;
      <td>4.11</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1003020R0AAAAAA&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Piroxicam 0.5% gel : 172</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1104020W0&amp;denomIds=11.4.2&amp;selectedTab=summary">Azelastine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>21</td>&#13;
      <td>Other anti-inflammatory preparations</td>&#13;
      <td>56</td>&#13;
      <td>0.38</td>&#13;
      <td>0.06</td>&#13;
      <td>0.08</td>&#13;
      <td>4.08</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1104020W0BBAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Optilast 0.05% eye drops : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1104020W0AAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Azelastine 0.05% eye drops : 19</a></div></td></tr></tbody></table>&#13;
&#13;
        <h2>Prescribing where Mendlesham Medical Group is lower than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0301020Q0&amp;denomIds=3.1.2&amp;selectedTab=summary">Tiotropium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>57</td>&#13;
      <td>Antimuscarinic bronchodilators</td>&#13;
      <td>195</td>&#13;
      <td>0.29</td>&#13;
      <td>0.71</td>&#13;
      <td>0.18</td>&#13;
      <td>-2.28</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0301020Q0AAAEAE&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 2.5micrograms/dose inhalation soln cart : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0301020Q0BCAAAD&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Braltus 10microgram inhalation pdr caps with Zonda inhaler : 6</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0301020Q0AAABAB&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 18microgram inhalation powder capsules : 20</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0301020Q0AAACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium brom 2.5microg/dose soln for inhalation CFCfree : 5</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0301020Q0AAADAD&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 10microgram inhalation pdr caps with dev : 5</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=0301020Q0BBACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln : 19</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1003020P0&amp;denomIds=10.3.2&amp;selectedTab=summary">Ibuprofen</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>43</td>&#13;
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>&#13;
      <td>404</td>&#13;
      <td>0.11</td>&#13;
      <td>0.52</td>&#13;
      <td>0.20</td>&#13;
      <td>-2.02</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1003020P0AAADAD&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Ibuprofen 5% spray : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1003020P0AAAIAI&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Ibuprofen 10% gel : 9</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1003020P0AAACAC&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Ibuprofen 5% gel : 21</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1003020P0BGAAAC&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Fenbid 5% gel : 6</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1003020P0BGABAI&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Fenbid Forte 10% gel : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1309000I0&amp;denomIds=13.9&amp;selectedTab=summary">Ketoconazole</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>9</td>&#13;
      <td>Shampoos and some other scalp preparations</td>&#13;
      <td>42</td>&#13;
      <td>0.21</td>&#13;
      <td>0.50</td>&#13;
      <td>0.16</td>&#13;
      <td>-1.79</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1309000I0AAAAAA&amp;denomIds=13.9&amp;selectedTab=summary" target="_blank">Ketoconazole 2% shampoo : 9</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1202020L0&amp;denomIds=12.2.2&amp;selectedTab=summary">Sodium chloride</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Topical nasal decongestants</td>&#13;
      <td>18</td>&#13;
      <td>0.00</td>&#13;
      <td>0.54</td>&#13;
      <td>0.31</td>&#13;
      <td>-1.72</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1104020T0&amp;denomIds=11.4.2&amp;selectedTab=summary">Sodium cromoglicate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>20</td>&#13;
      <td>Other anti-inflammatory preparations</td>&#13;
      <td>56</td>&#13;
      <td>0.36</td>&#13;
      <td>0.67</td>&#13;
      <td>0.18</td>&#13;
      <td>-1.70</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1104020T0AAAIAI&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Sodium cromoglicate 2% eye drops preservative free : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1104020T0AAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Sodium cromoglicate 2% eye drops : 4</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1104020T0BBAEAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Opticrom Allergy 2% eye drops : 4</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83019&amp;numIds=1104020T0AAAJAJ&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Sodium cromoglicate 2% eye dps 0.3ml ud preservative free : 10</a></div></td></tr></tbody></table>&#13;
&#13;
    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"/>&#13;
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"/>&#13;
</body>&#13;
&#13;
</html>